This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Neither the US Advisory Committee on Immunization Practices (ACIP)¹ nor the World Health Organization² recommendations for rabies postexposure prophylaxis contain specific guidelines for treating immunosuppressed patients. We present the first case report of a patient with lymphoma who was bitten by a rabid animal.

Report of a Case

Three weeks after being diagnosed with stage IV lymphocytic B-cell lymphoma, a 55-year-old man was attacked by a jackal. The patient experienced multiple bites on his right index finger, hand, forearm, and elbow and abdomen. At that time, he had not yet begun chemotherapy. Treatment in the emergency department included cleansing of the wounds and infiltration of the lacerations and abrasions with human rabies immunoglobulin (HRIG) 20 IU/kg (Berirab P; Centeon Pharma GmbH, Germany), and intramuscular injection of rabies vaccine (Rabipur; Chiron Behring GmbH, Germany). Rabies was later diagnosed in the jackal by using fluorescent brain microscopic examination. The patient received active rabies . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Overview, Prevention, and Treatment of Rabies
Hankins and Rosekrans
Mayo Clin Proc. 2004;79:671-676.
ABSTRACT  

Postexposure Rabies Prophylaxis in Immunosuppressed Patients
Gibbons et al.
JAMA 2001;285:1574-1575.
FULL TEXT